World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
143
Citations
67438
World Ranking
1522
National Ranking
883

Fazlul H. Sarkar publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Fazlul H. Sarkar sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 763 publications — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Fazlul H. Sarkar D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Fazlul H. Sarkar sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 143 D-Index — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Fazlul H. Sarkar is affiliated with Wayne State University in the United States. Their research focuses significantly on the fields of Biochemistry, Genetics and Molecular Biology, as well as Chemistry. Within these areas, Sarkar has contributed to subfields such as Cancer Research, Molecular Biology, Organic Chemistry, and Oncology.

The primary research topics associated with Sarkar include cancer-related molecular mechanisms, microRNA in disease regulation, circular RNAs in diseases, ferrocene chemistry and applications, metal complex synthesis and properties, and synthesis of tetrazole derivatives.

Sarkar's recent publications include:

  • "A health disparities study of MicroRNA-146a expression in prostate cancer samples derived from African American and European American patients" (2020, Journal of Solid Tumors)
  • "A Study to Investigate the Role of Noncoding RNA miR146 Alpha as a Potential Biomarker in Prostate Cancer" (2022, Journal of Analytical Oncology)
  • "A Novel Organometallic Rhenium Salt: DNA-Binding and Cytotoxicity Studies on Pancreatic, Breast and Lymphoma Cancers" (2021, Research Square (Research Square))

Frequent collaborators in Sarkar's work include Narendra Banerjee, Myla Worthington, Mukesh Verma, Santosh K. Mandal, and Hirendra Nath Banerjee. These coauthors have contributed collectively to multiple publications with Sarkar.

Sarkar's research appears in several scientific venues with recent works published in:

  • Journal of Solid Tumors
  • Journal of Analytical Oncology
  • Research Square (Research Square)

Best Publications

  • Exosomes in Cancer Development, Metastasis and Drug Resistance: A Comprehensive Review

    Asfar S. Azmi;Bin Bao;Fazlul H. Sarkar

  • Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin.

    Peter C. Brooks;Staffan Strömblad;Richard Klemke;Daniel Visscher

  • Up-regulation of miR-200 and let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer Cells

    Yiwei Li;Timothy G. VandenBoom;Dejuan Kong;Zhiwei Wang

  • Multi-targeted therapy of cancer by genistein

    Sanjeev Banerjee;Yiwei Li;Zhiwei Wang;Fazlul H. Sarkar

  • Acquisition of Epithelial-Mesenchymal Transition Phenotype of Gemcitabine-Resistant Pancreatic Cancer Cells Is Linked with Activation of the Notch Signaling Pathway

    Zhiwei Wang;Yiwei Li;Dejuan Kong;Sanjeev Banerjee

  • Antioxidant effect of zinc in humans.

    Ananda S. Prasad;Bin Bao;Frances W.J. Beck;Omer Kucuk

  • Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy

    Omer Kucuk;Fazlul H. Sarkar;Wael Sakr;Zora Djuric

  • Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF.

    Shadan Ali;Aamir Ahmad;Sanjeev Banerjee;Subhash Padhye

  • miR-146a suppresses invasion of pancreatic cancer cells

    Yiwei Li;Timothy G. VandenBoom;Zhiwei Wang;Dejuan Kong

  • Evolving role of uPA/uPAR system in human cancers

    Kathleen Dass;Aamir Ahmad;Asfar S. Azmi;Sarah H. Sarkar

  • Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an "intestinal" pathway of carcinogenesis in the pancreas.

    N. Volkan Adsay;Kambiz Merati;Olca Basturk;Christine Iacobuzio-Donahue

  • Soy Isoflavones and Cancer Prevention

    Fazlul H. Sarkar;Yiwei Li

  • Inactivation of Nuclear Factor κB by Soy Isoflavone Genistein Contributes to Increased Apoptosis Induced by Chemotherapeutic Agents in Human Cancer Cells

    Yiwei Li;Fakhara Ahmed;Shadan Ali;Philip A. Philip

  • Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells.

    Dejuan Kong;Sanjeev Banerjee;Aamir Ahmad;Yiwei Li

  • Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.

    Sreenivasa R Chinni;Yiwei Li;Sunil Upadhyay;Prathima K Koppolu

  • Cancer Stem Cells and Epithelial-to-Mesenchymal Transition (EMT)-Phenotypic Cells: Are They Cousins or Twins?

    Dejuan Kong;Yiwei Li;Zhiwei Wang;Fazlul H. Sarkar

  • Inhibition of Nuclear Factor κB Activation in PC3 Cells by Genistein Is Mediated via Akt Signaling Pathway

    Yiwei Li;Fazlul H. Sarkar

  • Novel Schiff base copper complexes of quinoline-2 carboxaldehyde as proteasome inhibitors in human prostate cancer cells.

    Shreelekha Adsule;Vivek Barve;Di Chen;Fakhara Ahmed

  • Down-regulation of Notch-1 inhibits invasion by inactivation of nuclear factor-κB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells

    Zhiwei Wang;Sanjeev Banerjee;Yiwei Li;K.M. Wahidur Rahman

  • Mechanisms of cancer chemoprevention by soy isoflavone genistein.

    Fazlul H. Sarkar;Yiwei Li

Frequent Co-Authors

Yiwei Li
Yiwei Li Wayne State University
Sanjeev Banerjee
Sanjeev Banerjee Wayne State University
Zhiwei Wang
Zhiwei Wang Soochow University
Bin Bao
Bin Bao Wayne State University
Subhash Padhye
Subhash Padhye Savitribai Phule Pune University
Philip A. Philip
Philip A. Philip Wayne State University
Wael Sakr
Wael Sakr Wayne State University
Shirish M. Gadgeel
Shirish M. Gadgeel University of Michigan–Ann Arbor
David J. Grignon
David J. Grignon Indiana University
Lucio Miele
Lucio Miele Louisiana State University Health Sciences Center New Orleans

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The journey to a medical career in the USA often involves exploring a variety of related health fields. For those interested in the science of nutrition and its impact on human health, pursuing one of the online nutrition degrees can be a flexible way to gain foundational knowledge and skills.

If you're focused on the business and leadership side of healthcare, consider enrolling in a program from the cahme accredited online mha programs list. These degrees are recognized for quality and can open doors to managerial roles in hospitals and health organizations.

Registered nurses aiming to further their education may benefit from online rn to bsn programs without clinicals. These programs are designed for working professionals who want to advance without the time commitment of extensive in-person requirements.

For nurses targeting the highest clinical qualifications, the shortest dnp programs offer a fast track to earn a Doctor of Nursing Practice degree online. This can enhance both leadership opportunities and earning potential.

Whether you're starting with nutrition, advancing as a nurse, or moving into healthcare administration, numerous online pathways support your medical career ambitions.

Best Scientists Citing Fazlul H. Sarkar

Trending Scientists

Recently Published Articles